- Home
- LPTH vs LXRX Comparison
LPTH vs LXRX Comparison
Compare LPTH & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LPTH | LXRX |
|---|---|---|
| Founded | 1985 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 563.1M | 660.9M |
| IPO Year | 2011 | 2000 |
Fundamental Metrics
Financial Performance| Metric | LPTH | LXRX |
|---|---|---|
| Price | $14.29 | $1.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $13.33 | $4.15 |
| AVG Volume (30 Days) | 1.9M | ★ 2.3M |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.78 |
| EPS | N/A | ★ N/A |
| Revenue | $37,202,630.00 | ★ $49,803,000.00 |
| Revenue This Year | $83.04 | N/A |
| Revenue Next Year | $24.83 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 17.26 | ★ 60.24 |
| 52 Week Low | $1.92 | $0.48 |
| 52 Week High | $15.24 | $1.84 |
Technical Indicators
Market Signals| Indicator | LPTH | LXRX |
|---|---|---|
| Relative Strength Index (RSI) | 66.61 | 57.49 |
| Support Level | $9.60 | $1.07 |
| Resistance Level | $15.24 | $1.81 |
| Average True Range (ATR) | 1.14 | 0.10 |
| MACD | 0.35 | 0.01 |
| Stochastic Oscillator | 92.29 | 65.71 |
Price Performance
Historical ComparisonAbout LPTH LightPath Technologies Inc.
LightPath Technologies Inc manufactures, distributes, and integrates proprietary optical components and assemblies. It develops optical solutions for traditional optics and communications markets. The company's products include precision molded optics and infrared products, serving markets such as distribution, laser, industrial, instrumentation, telecommunications, and defense. Its products are categorized as infrared components, visible components, assemblies and modules, and engineering services. G5 Infrared's revenue mainly comes from infrared components and assemblies.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.